333 related articles for article (PubMed ID: 30709400)
1. Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE.
Yue Y; Stanojlovic M; Lin Y; Karsenty G; Lin W
J Neuroinflammation; 2019 Feb; 16(1):23. PubMed ID: 30709400
[TBL] [Abstract][Full Text] [Related]
2. NF-κB Activation Accounts for the Cytoprotective Effects of PERK Activation on Oligodendrocytes during EAE.
Lei Z; Yue Y; Stone S; Wu S; Lin W
J Neurosci; 2020 Aug; 40(33):6444-6456. PubMed ID: 32661025
[TBL] [Abstract][Full Text] [Related]
3. Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis.
Lin W; Lin Y; Li J; Fenstermaker AG; Way SW; Clayton B; Jamison S; Harding HP; Ron D; Popko B
J Neurosci; 2013 Apr; 33(14):5980-91. PubMed ID: 23554479
[TBL] [Abstract][Full Text] [Related]
4. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases.
Lin Y; Huang G; Jamison S; Li J; Harding HP; Ron D; Lin W
Am J Pathol; 2014 Feb; 184(2):507-19. PubMed ID: 24269558
[TBL] [Abstract][Full Text] [Related]
5. Genetic inactivation of PERK signaling in mouse oligodendrocytes: normal developmental myelination with increased susceptibility to inflammatory demyelination.
Hussien Y; Cavener DR; Popko B
Glia; 2014 May; 62(5):680-91. PubMed ID: 24481666
[TBL] [Abstract][Full Text] [Related]
6. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage.
Lin W; Bailey SL; Ho H; Harding HP; Ron D; Miller SD; Popko B
J Clin Invest; 2007 Feb; 117(2):448-56. PubMed ID: 17273557
[TBL] [Abstract][Full Text] [Related]
7. Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases.
Stone S; Wu S; Jamison S; Durose W; Pallais JP; Lin W
Glia; 2018 Jul; 66(7):1331-1345. PubMed ID: 29436030
[TBL] [Abstract][Full Text] [Related]
8. Neuron-specific PERK inactivation exacerbates neurodegeneration during experimental autoimmune encephalomyelitis.
Stone S; Yue Y; Stanojlovic M; Wu S; Karsenty G; Lin W
JCI Insight; 2019 Jan; 4(2):. PubMed ID: 30674717
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation.
Madsen PM; Pinto M; Patel S; McCarthy S; Gao H; Taherian M; Karmally S; Pereira CV; Dvoriantchikova G; Ivanov D; Tanaka KF; Moraes CT; Brambilla R
J Neurosci; 2017 Oct; 37(42):10185-10199. PubMed ID: 28931570
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE.
Chaudhary P; Marracci GH; Calkins E; Pocius E; Bensen AL; Scanlan TS; Emery B; Bourdette DN
J Neuroimmunol; 2021 Mar; 352():577468. PubMed ID: 33422763
[TBL] [Abstract][Full Text] [Related]
11. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
12. ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis.
Hussien Y; Podojil JR; Robinson AP; Lee AS; Miller SD; Popko B
J Neurosci; 2015 Dec; 35(48):15921-33. PubMed ID: 26631473
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.
Stanojlovic M; Pang X; Lin Y; Stone S; Cvetanovic M; Lin W
PLoS One; 2016; 11(7):e0160158. PubMed ID: 27466819
[TBL] [Abstract][Full Text] [Related]
14. NF-κB Activation Protects Oligodendrocytes against Inflammation.
Stone S; Jamison S; Yue Y; Durose W; Schmidt-Ullrich R; Lin W
J Neurosci; 2017 Sep; 37(38):9332-9344. PubMed ID: 28842413
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress.
Lin W; Kemper A; Dupree JL; Harding HP; Ron D; Popko B
Brain; 2006 May; 129(Pt 5):1306-18. PubMed ID: 16504972
[TBL] [Abstract][Full Text] [Related]
16. Oligodendrocyte-Specific Deletion of
Rajendran R; Rajendran V; Giraldo-Velasquez M; Megalofonou FF; Gurski F; Stadelmann C; Karnati S; Berghoff M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502405
[TBL] [Abstract][Full Text] [Related]
17. Detection of PERK Signaling in the Central Nervous System.
Lei Z; Stone S; Lin W
Methods Mol Biol; 2022; 2378():233-245. PubMed ID: 34985704
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
19. Protective function of SLC30A10 induced via PERK-ATF4 pathway against 1-methyl-4-phenylpyridinium.
Go S; Kurita H; Yokoo K; Inden M; Kambe T; Hozumi I
Biochem Biophys Res Commun; 2017 Sep; 490(4):1307-1313. PubMed ID: 28688763
[TBL] [Abstract][Full Text] [Related]
20. PERK-eIF2α-ATF4 pathway mediated by endoplasmic reticulum stress response is involved in osteodifferentiation of human periodontal ligament cells under cyclic mechanical force.
Yang SY; Wei FL; Hu LH; Wang CL
Cell Signal; 2016 Aug; 28(8):880-6. PubMed ID: 27079961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
